Luker G D, Rao V V, Crankshaw C L, Dahlheimer J, Piwnica-Worms D
Laboratory of Molecular Radiopharmacology, Department of Radiology, Washington University Medical School, St. Louis, Missouri 63110, USA.
Biochemistry. 1997 Nov 18;36(46):14218-27. doi: 10.1021/bi971931z.
The multidrug resistance (MDR1) P-glycoprotein functions as a broad specificity efflux transporter of structurally diverse natural product and xenobiotic compounds. P-glycoprotein also is an important component of the functional blood-brain barrier. To enable further studies of function and modulation of MDR1 P-glycoprotein in vitro and in vivo, two novel phosphine technetium(III) complexes were designed and characterized: trans-[2,2'-(1, 2-ethanediyldiimino)bis(1, 5-methoxy-5-methyl-4-oxo-hexenyl)]bis[methylbis(3-methoxy-1- propyl)ph osphine]Tc(III) (Tc-Q58) and trans-[5,5'-(1,2-ethanediyl diimino)bis(2-ethoxy-2-methyl-3-oxo-4-pentenyl)]bis[dimethyl(3- methox y-1-propyl)phosphine)]Tc(III) (Tc-Q63). In human drug-sensitive KB 3-1 cells and multidrug-resistant KB 8-5 and 8-5-11 derivative cell lines, expressing nonimmunodetectable, low, and high levels of MDR1 P-glycoprotein, respectively, accumulation of Tc-Q58 and Tc-Q63 was inverse to expression of the transporter. Differences between drug-sensitive and multidrug-resistant cells, while detectable at picomolar concentrations of each radiopharmaceutical, were independent of tracer concentration. Ratios of tracer accumulation in KB 3-1 and 8-5 cells were 62.3 and 48.1 for Tc-Q58 and Tc-Q63, respectively. Cell contents of Tc-Q58 and Tc-Q63 were enhanced up to 60-fold in MDR cells by known modulators of MDR1 P-glycoprotein, while drugs not in the multidrug-resistant phenotype had no effect on their accumulation. In KB 8-5 cells, potency of modulators was GF120918 >> cyclosporin A > verapamil. Accumulation of Tc-Q58 and Tc-Q63 in Sf9 insect cells infected with a recombinant baculovirus containing human MDR1 P-glycoprotein was reduced in a GF120918-reversible manner (EC50 </= 70 nM) compared with cells infected with a wild-type baculovirus. By contrast, cell contents of Tc-Q58 or Tc-Q63 in Sf9 cells expressing the homologous MDR3 P-glycoprotein did not differ from wild-type virus. Demonstrating molecular targeting of these complexes in vivo, distribution and retention of Tc-Q58 in brain tissue of FVB mice treated with a saturating dose of GF120918 and mice deficient in the mdr1a gene [mdr1a (-/-)] were enhanced 180% and 520% over control, respectively. Exploiting the gamma-emission spectrum of 99mTc, increased uptake of Tc-Q58 in brain tissue of mdr1a (-/-) mice was readily detected noninvasively by scintigraphic imaging. Thus, both Tc-Q58 and Tc-Q63 are demonstrated to be substrates for transport by MDR1 P-glycoprotein, broadening the specificity of this transporter to include phosphine-containing metal complexes. As shown with Tc-Q58, these Q complexes can be used to detect transport activity and modulation of MDR1 P-glycoprotein in vitro and to directly monitor the functional status of P-glycoprotein at the blood-brain barrier in vivo.
多药耐药(MDR1)P-糖蛋白作为结构多样的天然产物和外源性化合物的广泛特异性外排转运体发挥作用。P-糖蛋白也是功能性血脑屏障的重要组成部分。为了能够在体外和体内进一步研究MDR1 P-糖蛋白的功能及其调节作用,设计并表征了两种新型的膦锝(III)配合物:反式-[2,2'-(1,2-乙二胺二亚氨基)双(1,5-甲氧基-5-甲基-4-氧代己烯基)]双[甲基双(3-甲氧基-1-丙基)膦]Tc(III)(Tc-Q58)和反式-[5,5'-(1,2-乙二胺二亚氨基)双(2-乙氧基-2-甲基-3-氧代-4-戊烯基)]双[二甲基(3-甲氧基-1-丙基)膦]Tc(III)(Tc-Q63)。在人药物敏感的KB 3-1细胞以及多药耐药的KB 8-5和8-5-11衍生细胞系中,它们分别表达不可免疫检测的、低水平和高水平的MDR1 P-糖蛋白,Tc-Q58和Tc-Q63的蓄积与转运体的表达呈负相关。药物敏感细胞和多药耐药细胞之间的差异,虽然在每种放射性药物的皮摩尔浓度下均可检测到,但与示踪剂浓度无关。Tc-Q58和Tc-Q63在KB 3-1和8-5细胞中的示踪剂蓄积比分别为62.3和48.1。已知的MDR1 P-糖蛋白调节剂可使MDR细胞中Tc-Q58和Tc-Q63的细胞含量增加多达60倍,而不具有多药耐药表型的药物对它们的蓄积没有影响。在KB 8-5细胞中,调节剂的效力为GF120918 >> 环孢素A > 维拉帕米。与感染野生型杆状病毒的细胞相比,感染含人MDR1 P-糖蛋白的重组杆状病毒的Sf9昆虫细胞中Tc-Q58和Tc-Q63的蓄积以GF120918可逆的方式降低(EC50≤70 nM)。相比之下,表达同源MDR3 P-糖蛋白的Sf9细胞中Tc-Q58或Tc-Q63的细胞含量与野生型病毒无差异。在用饱和剂量的GF120918处理的FVB小鼠和mdr1a基因缺陷的小鼠[mdr1a(-/-)]的脑组织中,Tc-Q58的分布和滞留分别比对照增强了180%和520%,这证明了这些配合物在体内的分子靶向性。利用99mTc的γ发射光谱,通过闪烁成像可以很容易地无创检测到mdr1a(-/-)小鼠脑组织中Tc-Q58摄取的增加。因此,已证明Tc-Q58和Tc-Q63都是MDR1 P-糖蛋白转运的底物,拓宽了该转运体的特异性,使其包括含膦金属配合物。如Tc-Q58所示,这些Q配合物可用于体外检测MDR1 P-糖蛋白的转运活性及其调节作用,并直接监测体内血脑屏障处P-糖蛋白的功能状态。